Apixio receives $13.5 million in funding
Apixio has received $13.5 million in Series C funding from Bain Capital Ventures and several angel investors. What does Apixio do? Apixio extracts data from different types of medical data like patient charts and doctors’ notes to help hospitals and insurance companies understand patients’ health for risk assessment purposes.
Apixio has raised over $22 million since launching in 2009. The company launched in 2011. At that time, the company focused on building its semantic-analysis engine for identifying latent connections between diagnoses and symptoms.
Apixio is setting out to develop a connected world where medical information becomes liquid, enabling hosts of existing and new technology providers to search and analyze display medical information. Apixio has now raised a total of over $22 million in funding.